These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects. Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217 [TBL] [Abstract][Full Text] [Related]
7. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies. Müller MA; Clur SA; Timmerman E; Bilardo CM Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215 [TBL] [Abstract][Full Text] [Related]
8. Increased nuchal translucency and normal karyotype: coping with uncertainty. Bilardo CM Ultrasound Obstet Gynecol; 2001 Feb; 17(2):99-101. PubMed ID: 11251914 [No Abstract] [Full Text] [Related]
9. [Enlarged nuchal translucency with normal karyotype]. Oueslati A; Amroussi A; Youssef A; Ben Ghezala M; Agrebi W; Ben Mefteh M; Oueslati H Tunis Med; 2008 Jun; 86(6):617-8. PubMed ID: 19216466 [No Abstract] [Full Text] [Related]
10. Nuchal translucency and its relationship to congenital heart disease. Devine PC; Simpson LL Semin Perinatol; 2000 Oct; 24(5):343-51. PubMed ID: 11071375 [TBL] [Abstract][Full Text] [Related]
11. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183 [TBL] [Abstract][Full Text] [Related]
12. Increased nuchal translucency in fetuses with a normal karyotype. Hyett JA Prenat Diagn; 2002 Oct; 22(10):864-8. PubMed ID: 12378566 [No Abstract] [Full Text] [Related]
13. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Makrydimas G; Sotiriadis A; Ioannidis JP Am J Obstet Gynecol; 2003 Nov; 189(5):1330-5. PubMed ID: 14634564 [TBL] [Abstract][Full Text] [Related]
14. Early prenatal diagnosis of major congenital heart defects. Carvalho JS Curr Opin Obstet Gynecol; 2001 Apr; 13(2):155-9. PubMed ID: 11315870 [TBL] [Abstract][Full Text] [Related]
15. Screening for Down's syndrome. Nuchal translucency screening may help detect congenital heart disease. Simpson JM BMJ; 2002 Jan; 324(7329):112. PubMed ID: 11808525 [No Abstract] [Full Text] [Related]
16. Search for hemodynamic compromise at 11-14 weeks in monochorionic twin pregnancy: is abnormal flow in the ductus venosus predictive of twin-twin transfusion syndrome? Matias A; Ramalho C; Montenegro N J Matern Fetal Neonatal Med; 2005 Aug; 18(2):79-86. PubMed ID: 16203591 [TBL] [Abstract][Full Text] [Related]
17. Fetal nuchal translucency and normal chromosomes: a long-term follow-up study. Hiippala A; Eronen M; Taipale P; Salonen R; Hiilesmaa V Ultrasound Obstet Gynecol; 2001 Jul; 18(1):18-22. PubMed ID: 11489219 [TBL] [Abstract][Full Text] [Related]
18. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ghi T; Huggon IC; Zosmer N; Nicolaides KH Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199 [TBL] [Abstract][Full Text] [Related]